Back to search

Article

Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study

2021-04-14

Abstract excerpt

Background: Vaccines are urgently needed to tackle the unprecedented morbidity and mortality of COVID-19. Administration of inactivated viruses are the common and mature platform of developing new vaccines. CoronaVac is an inactivated vaccine that has undergone preclinical tests and phase I/II clinical trials.<br><br>Methods: We conducted a randomised, double-blind, placebo-controlled phase 3 clinical trial with C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6ca78c3-f55c-5f15-8871-b85693ca86f7
DOI
10.2139/ssrn.3822780
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV StudyDOI 10.2139/ssrn.3822780
Select a neighboring publication to make it the new centre.